Unexpected effects of FERM domain mutations on catalytic activity of Jak3: Structural implication for Janus kinases

被引:109
|
作者
Zhou, YJ
Chen, M
Cusack, NA
Kimmel, LH
Magnuson, KS
Boyd, JG
Lin, W
Roberts, JL
Lengi, A
Buckley, RH
Geahlen, RL
Candotti, F
Gadina, M
Changelian, PS
O'Shea, JJ [1 ]
机构
[1] NIAMSD, Lymphocyte Cell Biol Sect, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA
[2] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA
[3] Pfizer Inc, Global Res & Dev, Dept Immunol, Groton, CT 06340 USA
[4] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27710 USA
[5] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
关键词
D O I
10.1016/S1097-2765(01)00398-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Janus kinases comprise carboxyterminal kinase, pseudokinase, SH2-like, and N-terminal FERM domains. We identified three patient-derived mutations in the FERM domain of Jak3 and investigated the functional consequences of these mutations. These mutations inhibited receptor binding and also abrogated kinase activity, suggesting interactions between the FERM and kinase domains. In fact, the domains were found to physically associate, and coexpression of the FERM domain enhanced activity of the isolated kinase domain. Conversely, staurosporine, which alters kinase domain structure, disrupted receptor binding, even though the catalytic activity of Jak3 is dispensable for receptor binding. Thus, the Jak FERM domain appears to have two critical functions: receptor interaction and maintenance of kinase integrity.
引用
收藏
页码:959 / 969
页数:11
相关论文
共 34 条
  • [21] Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (Il2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-STAT signaling machinery
    Witthuhn, BA
    Williams, MD
    Kerawalla, H
    Uckun, FM
    LEUKEMIA & LYMPHOMA, 1999, 32 (3-4) : 289 - 297
  • [22] Effects Of VX-509, An Investigational Oral Selective Janus Kinase 3 (JAK3) Inhibitor, On Patient-Reported Outcomes In a Phase 2A Study Of Patients With Active Rheumatoid Arthritis
    Strand, Vibeke
    Suthoff, Ellison
    Fleischmann, Roy M.
    Vera-Llonch, Montserrat
    Jiang, John
    Zhang, Yanqiong
    Kinnman, Nils
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1004 - S1005
  • [23] Structural effects of a dimer interface mutation on catalytic activity of triosephosphate isomerase The role of conserved residues and complementary mutations
    Banerjee, Mousumi
    Balaram, Hemalatha
    Balaram, Padmanabhan
    FEBS JOURNAL, 2009, 276 (15) : 4169 - 4183
  • [24] Pathogenic mutations in the carboxyl-terminal domain of glutaryl-CoA dehydrogenase: effects on catalytic activity and the stability of the tetramer
    Westover, JB
    Goodman, SI
    Frerman, FE
    MOLECULAR GENETICS AND METABOLISM, 2003, 79 (04) : 245 - 256
  • [25] Revealing insights into the unexpected effects of ZnO on selective catalytic reduction (SCR) activity of the CeOx-WO3 catalyst
    Ye, Dong
    Xu, Yifeng
    Feng, Jingyi
    Wang, Qingshan
    Sun, Li
    Zhu, Kai
    Guo, Ruitang
    FUEL, 2025, 381
  • [26] Effects of inherited mutations on catalytic activity and structural stability of human glucose-6-phosphate isomerase expressed in Escherichia coli
    Lin, Hua-Yang
    Kao, Ya-Heui
    Chen, Shu-Ting
    Meng, Menghsiao
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2009, 1794 (02): : 315 - 323
  • [27] Combined effects of double mutations on catalytic activity and structural stability contribute to clinical manifestations of glucose-6-phosphate dehydrogenase deficiency
    Phonchanan Pakparnich
    Sirapapha Sudsumrit
    Mallika Imwong
    Teeraporn Suteewong
    Kamonwan Chamchoy
    Danaya Pakotiprapha
    Ubolsree Leartsakulpanich
    Usa Boonyuen
    Scientific Reports, 11
  • [28] Combined effects of double mutations on catalytic activity and structural stability contribute to clinical manifestations of glucose-6-phosphate dehydrogenase deficiency
    Pakparnich, Phonchanan
    Sudsumrit, Sirapapha
    Imwong, Mallika
    Suteewong, Teeraporn
    Chamchoy, Kamonwan
    Pakotiprapha, Danaya
    Leartsakulpanich, Ubolsree
    Boonyuen, Usa
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [29] 3D Modeling of Novel Transforming JAK Mutations in T-Cell Acute Lymphoblastic Leukemia Reveals Altered Pseudokinase-Kinase Domain Interactions That Result in Constitutive JAK Kinase Activity
    Cante-Barrett, Kirsten
    Uitdehaag, Joost C. M.
    Buijs-Gladdines, Jessica G. C. A. M.
    Smits, Wilco K.
    Buijsman, Rogier C.
    Zaman, Guido J. R.
    Pieters, Rob
    Meijerink, Jules P. P.
    BLOOD, 2015, 126 (23)
  • [30] Effects of JAK2 V556F mutation on the JAK2's activity, structural stability and the transformation of Ba/F3 cells
    Wu, Qing-Yun
    Ma, Meng -Meng
    Tong, Yu-Xue
    Zhu, Yuan -Yuan
    Liu, Yang
    Cao, Jiang
    Zhou, Ping
    Li, Zhen-Yu
    Zeng, Ling -Yu
    Wang, Xiao-Yun
    Li, Feng
    Xu, Kai -Lin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 117 : 271 - 279